Clinical Trials Report Card
- 30 March 2006
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 354 (13) , 1426-1429
- https://doi.org/10.1056/nejmc066024
Abstract
In the editorial, with Dr. Wood, on registration of clinical trials (Dec. 29 issue),1 you unfairly criticize Pfizer and falsely claim that companies challenge the “spirit of the law.” Pfizer's record is demonstrably excellent. Section 113 of the Food and Drug Administration Modernization Act (FDAMA 113) established ClinicalTrials.gov to help patients find clinical trials and new treatments for serious and life-threatening conditions. Pfizer has rigorously complied with the letter and the spirit of this law.Keywords
This publication has 8 references indexed in Scilit:
- Registries and Registration of Clinical TrialsNew England Journal of Medicine, 2005
- Trial Registration Report CardNew England Journal of Medicine, 2005
- Trial Registration at ClinicalTrials.gov between May and October 2005New England Journal of Medicine, 2005
- Is this clinical trial fully registered? A statement from the International Committee of Medical Journal EditorsThe Lancet, 2005
- Clinical Trial Registration: A Statement from the International Committee of Medical Journal EditorsNew England Journal of Medicine, 2004
- The power of the protocolThe Lancet, 2002
- Conflict of interest and medical publication.Science and Engineering Ethics, 2002
- Are research ethics committees behaving unethically? Some suggestions for improving performance and accountabilityBMJ, 1996